Theralase Technologies (TLT) News Today C$0.28 0.00 (0.00%) As of 02/21/2025 03:09 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Theralase Technologies (CVE:TLT) Trading 3.5% Higher - Time to Buy?Theralase Technologies (CVE:TLT) Shares Up 3.5% - Still a Buy?February 19 at 4:04 AM | marketbeat.comTheralase Technologies, Inc.: CORRECTING AND REPLACING: Theralase Demonstrates Effective Treatment of HerpesFebruary 13, 2025 | finanznachrichten.deTheralase Technologies, Inc.: Theralase Demonstrates Effective Treatment of HerpesFebruary 12, 2025 | finanznachrichten.deTheralase(R) Releases Latest Research on Inactivation of Herpes Simplex VirusesFebruary 11, 2025 | theglobeandmail.comTheralase achieves breakthrough Herpes treatmentFebruary 10, 2025 | msn.comTheralase Technologies, Inc.: Theralase Releases Latest Research on Inactivation of Herpes Simplex VirusesFebruary 10, 2025 | finanznachrichten.deTheralase Technologies (CVE:TLT) Trading Up 14.3% - Still a Buy?Theralase Technologies (CVE:TLT) Trading Up 14.3% - Time to Buy?January 28, 2025 | marketbeat.comTheralase Technologies (CVE:TLT) Trading Up 10.2% - What's Next?Theralase Technologies (CVE:TLT) Shares Up 10.2% - Here's What HappenedJanuary 28, 2025 | marketbeat.comTheralase’s Innovative Bladder Cancer Treatment to be Highlighted at AUA Annual MeetingJanuary 28, 2025 | msn.comTheralase Technologies, Inc.: Theralase Interim Clinical Data to be Presented at the 2025 AUA Annual MeetingJanuary 27, 2025 | finanznachrichten.deTheralase Technologies (CVE:TLT) Stock Price Down 1.6% - Here's WhyTheralase Technologies (CVE:TLT) Trading Down 1.6% - Should You Sell?January 11, 2025 | marketbeat.comTheralase Technologies (CVE:TLT) Shares Down 7.4% - Here's WhyTheralase Technologies (CVE:TLT) Trading Down 7.4% - Time to Sell?December 21, 2024 | marketbeat.comTheralase(R) Launches New Clinical Study Site in CanadaDecember 5, 2024 | stockhouse.comTheralase Technologies Inc. (TLTFF) Q3 2024 Earnings Call TranscriptDecember 5, 2024 | seekingalpha.comTheralase Technologies Extends Warrant Expiry DateNovember 13, 2024 | markets.businessinsider.comTheralase Technologies Inc. (TLT.V)October 27, 2024 | ca.finance.yahoo.comTheralase Technologies (CVE:TLT) Trading Down 15.8% - Time to Sell?Theralase Technologies (CVE:TLT) Shares Down 15.8% - Here's What HappenedOctober 22, 2024 | marketbeat.comTheralase Technologies (CVE:TLT) Shares Up 21.1% - What's Next?Theralase Technologies (CVE:TLT) Trading Up 21.1% - Here's WhyOctober 21, 2024 | marketbeat.comThree Canadian small-caps stocks for a contrarian investmentOctober 11, 2024 | msn.comLatest data from bladder cancer study to propel future growthOctober 10, 2024 | msn.comTheralase’s bladder cancer drug under investigation in clinical studyOctober 7, 2024 | msn.comTheralase Technologies, Inc.: Theralase Extends WarrantsSeptember 19, 2024 | finanznachrichten.deTheralase Technologies, Inc.: Rutherrin Increases Efficacy of Chemotherapy for Lung CancerAugust 28, 2024 | finanznachrichten.deRutherrin(R) Increases Efficacy of Chemotherapy for Lung CancerAugust 28, 2024 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - TLT.WTAugust 22, 2024 | finance.yahoo.comStocks in play: Theralase® Technologies Inc.August 21, 2024 | ca.finance.yahoo.comPharma stock Theralase paves way for in-home cancer treatmentAugust 21, 2024 | msn.comTheralase Technologies Inc. (TLTFF) Q2 2024 Earnings Call TranscriptAugust 21, 2024 | seekingalpha.comTheralase Technologies, Inc.: Theralase Demonstrates Unique Ability to Activate Rutherrin With Diabetes DrugAugust 21, 2024 | finanznachrichten.deTheralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes DrugAugust 21, 2024 | finance.yahoo.comTheralase Technologies Inc (TTX.SG)August 16, 2024 | finance.yahoo.comThree micro-cap value stocks to hold for a decadeAugust 16, 2024 | msn.comTheralase Technologies Second Quarter 2024 Earnings: CA$0.005 loss per share (vs CA$0.005 loss in 2Q 2023)August 14, 2024 | finance.yahoo.comTheralase Technologies: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (TLT)August 6, 2024 | theglobeandmail.comTheralase(R) Expands Clinical TeamMay 2, 2024 | finance.yahoo.comTheralase Technologies Inc.: Theralase Closes $CAN 750,000 Non-Brokered Private PlacementApril 24, 2024 | finanznachrichten.deTheralase Technologies Inc.: Theralase Granted Canadian Cancer Vaccine PatentApril 5, 2024 | finanznachrichten.deTheralase(R) Granted Canadian Cancer Vaccine PatentApril 5, 2024 | finance.yahoo.comTheralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological AssociationMarch 26, 2024 | finance.yahoo.comClosing Bell: Theralase Technologies Inc flat on Friday (TLT)March 16, 2024 | theglobeandmail.comTheralase Technologies Inc TLTMarch 1, 2024 | morningstar.comTheralase Technologies Inc.: Theralase Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's DiseaseFebruary 12, 2024 | finanznachrichten.deTheralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's DiseaseFebruary 12, 2024 | finance.yahoo.comDr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyFebruary 8, 2024 | finance.yahoo.comTheralase Technologies Inc.: Theralase Closes $CAN 1.2 Million Non-Brokered Private PlacementFebruary 5, 2024 | finanznachrichten.deTheralase(R) Closes $CAN 1.2 Million Non-Brokered Private PlacementFebruary 5, 2024 | finance.yahoo.comTheralase Technologies Inc.: Theralase Provides Update on Phase II Bladder Cancer Clinical StudyJanuary 15, 2024 | finanznachrichten.deTheralase makes positive progress on Phase II study on...Theralase makes positive progress on Phase II study on bladder...December 1, 2023 | proactiveinvestors.comTheralase concludes $1.17M private placement for cancer treatment advancementsNovember 30, 2023 | proactiveinvestors.comTheralase focused on breakthrough designation after positive preliminary study dataNovember 30, 2023 | proactiveinvestors.com Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address TLT Media Mentions By Week TLT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLT News Sentiment▼0.750.60▲Average Medical News Sentiment TLT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLT Articles This Week▼10▲TLT Articles Average Week Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Profound Medical News Titan Medical News Quipt Home Medical News MedX Health News Aurora Spine News VentriPoint Diagnostics News Imaging Dynamics News Medical Facilities News Organigram News Cipher Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:TLT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theralase Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theralase Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLT Stock Alerts